Siglion Therapeutics

After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes
BioSpace
Thu, 07/13/23 - 10:11 am
CellTrans
Lantidra
type 1 diabetes
cell therapy
Eli Lilly
Siglion Therapeutics
Biopharma’s green shoots thriving in summer sun as deal activity returns
Fierce Biotech
Tue, 07/11/23 - 11:18 pm
M&A
Eli Lilly
Siglion Therapeutics
DiCE Therapeutics
GSK
Bellus Health
Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go
Endpoints
Wed, 03/15/23 - 09:24 pm
Siglion Therapeutics
type 1 diabetes
cell therapy
Sigilon Uncovers Possible Reason Behind Hemophilia A Trial Hold
BioSpace
Tue, 11/30/21 - 10:28 am
Siglion Therapeutics
cell therapy
FDA
hemophilia A
SIG-001
Sigilon picks up $80M to test hemophilia cell therapy in humans
Fierce Biotech
Sat, 03/21/20 - 02:02 pm
Siglion Therapeutics
cell terhapy
hemophilia